We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ideagen Plc | LSE:IDEA | London | Ordinary Share | GB00B0CM0C50 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 349.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/11/2014 09:02 | It starts tomorrow and a great opportunity to see IDEA on all three days There will be nearly 60 companies there through the three days of the event. SPRP,RTC,ZZZ,IDEA,PE The speakers include a who's who of the UK investment landscape with the likes of Katie Potts, Giles Hargreaves, Lord John Lee & Gervais Williams delivering keynote talks throughout the event alongside the 60 companies exhibiting, with many presenting. If any of you want half price tickets then just use my MELLO-DISCOUNT code and I hope to see you there. | davidosh | |
05/11/2014 08:56 | RNS Nuclear industry contract David Hornsby, Ideagen Chief Executive commented: "The resurgent Nuclear Energy sector continues to be a key market for Ideagen and we are seeing progress on a number of high-profile projects. We look forward to a beneficial long term relationship working with the NuGen team to deliver a world-class system to support quality, safety, compliance and operational efficiency." | 43rick | |
10/10/2014 09:26 | Availed myself of some. | kemche | |
07/10/2014 15:55 | Ideagen will be presenting at our next growth company seminar in London on the 23rd October if anyone is interested in attending. More details at... | sharesoc | |
03/10/2014 06:41 | Thank you for your efforts here GHF, much appreciated | chizgreen68 | |
02/10/2014 22:59 | Header updated to reflect news, earnings record and forecasts for the current year. I'll tidy it up further when opportunity arises. finnCap indicate, Largest contract win, and trading update "Alongside a trading update revealing 1H performance in line with unchanged expectations for the year to April, Ideagen has announced its largest NHS contract win to date. The £1m contract, of which 65% of the value accrues to the current year, is for provision of dart/KW to Doncaster and Bassetlaw Hospitals NHS Foundation Trust, enabling digitisation and consolidation of records across sites and functions to make sure patient information is available at point of care. The win reiterates the fact that dart/KW is well positioned to compete for similar contracts available from the 75% of trusts which are yet to implement a similar, required, solution. 1H trading is robust, with strong growth on last year, and the integration of EIBS, acquired in April, successfully completed. Target 50p reiterated, with a continuing expectation for both organic growth and growth from acquisitions." While the respected TechMarketView also comment; Information management software provider Ideagen is continuing to see success in the UK healthcare market. It’s just signed its largest single NHS contract to date, a £1m deal with Doncaster and Bassetlaw Hospitals NHS Foundation Trust for the supply and implementation of its dart/KW ‘patient information solution’. The software enables the Trust to digitise and consolidate patient records across a number of sites to ensure patient information is available at the point of care. This fits nicely with the Government’s drive to make the NHS paperlite by 2018 (see Hunt wants ‘paperlessR The contract value - 65% of which is expected to be recognised in the current financial year - will also provide a significant financial boost to Ideagen, which turned over £9m in the year to end of April 2014 (see Ideagen’s organic growth boosted by NHS business). With trading described as ‘robust’ in all areas of the business, both revenues and adjusted EBITDA for the first half are predicted to show significant growth over the same period last year. It’s encouraging to see growth supported by both a strong organic performance and the acquisition of EIBS (see here), which has now been successfully integrated. As we said back in March, Ideagen is now firmly on our ‘ones to watch’ list in NHS IT (see Ideagen proves 'one to watch' in NHS IT)." --- Personally, I'm delighted with the progress DH & the team are making. Long may it continue. Regards, GHF | glasshalfull | |
02/10/2014 08:12 | Sorry to say, I thought the video was really poor. It starts well with the nice graphics etc but just becomes long, boring and repetitive. The key thing for me was, it never answered the key question, 'what is CMT?'. I'm still none the wiser! Not really impressed at all. | gohilster | |
02/10/2014 07:34 | And they keep their new clients, lovely steady grower. | chizgreen68 | |
02/10/2014 06:55 | Well done indeed :-) | cheshire man | |
02/10/2014 06:23 | Well done to DH & the team on delivering such a prestigious contract win & excellent trading update. Per my tweet, @Glasshalfull1: IDEA @Ideagen_Plc - Strong t/s this morning with largest contract win. Underpins 2p EPS (20% growth) this year #TMFPP Regards GHF | glasshalfull | |
16/9/2014 15:46 | Its a catchy little video. | bu5boy | |
16/9/2014 14:38 | Ideagen Plc @Ideagen_Plc 9m Introducing Ideagen Plc's CMT. Watch our brand new video here >> | cheshire man | |
16/9/2014 13:17 | News needed here. | bu5boy | |
16/9/2014 13:16 | Small buys going through as sells. | bu5boy | |
21/8/2014 10:09 | Yes. Ready for a push up. | hutch_pod | |
21/8/2014 08:42 | Showing a bit of leg this morning. I would like to think that decline from ath may be a bit overdone here | chizgreen68 | |
30/7/2014 18:47 | Thanks Hutch_Pod - Just calculating if the fundamentals are still good. | welsheagle | |
30/7/2014 14:07 | £4m is roughly 3p. why? Looks like a contract win is needed to bring back the buyers | hutch_pod | |
22/7/2014 19:46 | How much does £4m in cash work out in pence per share. | welsheagle | |
22/7/2014 10:41 | The trades are only showing @ £25k of sells, not really significant to be fair | chizgreen68 | |
22/7/2014 10:34 | Good article. Yes the selling is confusing. | hutch_pod | |
22/7/2014 09:50 | Interesting read thanks for posting :-) | cheshire man | |
22/7/2014 09:44 | TechMarketViews thoughts on results:- "After updating on its full year back in May (see here), compliance-based information management software provider Ideagen has delivered an impressive set of results for what is its first full year of trading since admission to AIM on 2nd July 2012 (see here). Headline revenue for the year ended 30 April was up 38% to £9m, and pre-tax profits were up 36% to £2.6m, which kept the margin steady at a healthy 29%. Of course Ideagen has been making acquisitions over the past year or so notably in the UK healthcare and compliance sectors (see here and work back). Nonetheless, organic growth was still 13%. It appears that all the organic growth was from Ideagen's healthcare (NHS-focused) business, which grew organically by 16%. This was helped by the release of a new product, dart/KW, an enterprise scale Patient Information solution, and re-organisation, moving sales and technical resources from its commercial business into the NHS team. Dart/KW looks set to be a significant new opportunity area for Ideagen. Management estimates that only 25% of the 192 NHS Trusts in the UK have implemented a trust-wide patient document repository Ideagen has supplied 10 trusts to date, or 5% of that addressable market. Last month's acquisition of EIBS (see here) should also help since it adds capability in the area of web portals. Ideagen now intends to bring this capability together with Dart/KW to offer 'trust wide information portals that can offer a single view of patient information from multiple data sources'. This sounds like Ideagen will be edging closer towards much larger rival EMIS, which is carving out its turf in 'connected health Regards GHF | glasshalfull |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions